The Wait Is Over: How BioSerenity Is Bringing Neurologist-Level Diagnostics to Your Bedside

Patients with neurological or sleep disorders often wait weeks for diagnostic answers while symptoms worsen. Equipment sits in specialized labs, neurologists are concentrated in major centers, and rural or smaller hospitals struggle to access expertise. BioSerenity is redesigning this model.

BioSerenity has built a distributed approach to electrophysiology, combining portable devices, secure cloud workflows, and 24/7 specialist interpretation. The goal is simple: deliver hospital-grade diagnostics wherever the patient is.

At the center of this system are two core technologies.

• Neuronaute+, an FDA-cleared, lightweight EEG platform, enables recordings in environments ranging from ICUs to patients’ homes. Data can be reviewed locally, then uploaded securely for remote specialist analysis.

• ICECap, a disposable electrode system available from neonate to adult sizes, reduces setup complexity while supporting extended monitoring durations.

But hardware is only part of the solution. BioSerenity operates dedicated tele-interpretation networks for EEG, sleep studies, and cardiac monitoring, providing continuous access to expert readers, rapid turnaround times, and emergency coverage. For many hospitals, this effectively brings tertiary-center expertise to community settings.

• Thousands of physicians actively using the platform

• Hundreds of hospitals as partners

• 1+ million patients served across neurology and sleep medicine

• €24 million fresh investment from Jolt Capital for international expansion

BioSerenity proves that “healthcare access” doesn’t have to mean “building more hospitals” or “training more specialists.” Sometimes it means rethinking where and how diagnostics happen. BioSerenity pairs portable testing, cloud workflows, and rapid specialist reads to maintain quality while eliminating geographic barriers. Diagnostics are now distributed, connected, and patient centered.